Urologic and sexual morbidity following multimodality treatment for locally advanced primary and locally recurrent rectal cancer

Citation
Ghh. Mannaerts et al., Urologic and sexual morbidity following multimodality treatment for locally advanced primary and locally recurrent rectal cancer, EUR J SUR O, 27(3), 2001, pp. 265-272
Citations number
51
Categorie Soggetti
Oncology
Journal title
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
ISSN journal
07487983 → ACNP
Volume
27
Issue
3
Year of publication
2001
Pages
265 - 272
Database
ISI
SICI code
0748-7983(200104)27:3<265:UASMFM>2.0.ZU;2-#
Abstract
Aims: In the treatment of patients with locally advanced primary or locally recurrent rectal cancer much attention is given to the oncological aspects . In long-term survivors, urogenital morbidity can have a large effect on t he quality of life. This study evaluates the functional outcome after multi modality treatment in these patient groups. Patients and methods: Between 1994 and August 1999, 55 patients with locall y advanced primary and 66 patients with locally recurrent rectal cancer wer e treated with multimodality treatment: i.e. high-dose preoperative externa l beam radiation therapy, followed by extended surgery and intraoperative r adiotherapy. The medical records of the 121 patients were reviewed. To asse ss long-term urogenital morbidity, all patients still alive, with a minimum followup of 4 months, were asked to fill out a questionnaire about their v oiding and sexual function. Seventy-six of the 79 currently living patients (96%) returned the questionnaire (median FU 14 months, range 4-60). Results: The questionnaire revealed identifiable voiding dysfunction as a n ew problem in 31% of the male and 58% of the female patients. In 42% of pat ients after locally advanced primary and 48% after locally recurrent rectal cancer treatment bladder dysfunction occurred. The preoperative ability to have an orgasm had disappeared in 50% of the male and 50% of the female pa tients, and in 45% of patients after locally advanced primary and in 57% af ter locally recurrent rectal cancer treatment. Conclusion: Multimodality treatment for locally advanced primary and recurr ent rectal cancer results in acceptable urogenital dysfunction if weighed b y the risk of uncontrolled tumour progression. Long-term voiding and sexual function is decreased in half of the patients. Preoperative counselling of these patients on treatment-related urogenital morbidity is important. (C) 2001 Harcourt Publishers Ltd.